• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION DUO-VENT CLEARLINK LUER ACTIVATED VALVE; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION DUO-VENT CLEARLINK LUER ACTIVATED VALVE; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 2C8419
Device Problem Break (1069)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Manufacturer Narrative
This event occurred during the unspecified date of (b)(6) 2020.(b)(6).Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that when twisting, the luer lock of 5 clearlink system solution sets broke.This was identified during preparation.There was no patient involvement.No additional information is available.
 
Manufacturer Narrative
H10: one (1) actual sample was received for evaluation.The other four (4) devices were not received and therefore, could not be evaluated.The sample was received out of the pouch fully primed.No visual residue of propofol was noted on the luer collar.It was observed that the male luer collar was broken, however, it was reported that the nurses use chlorhexidine to clean the luer lock prior to connection.The disinfectant chlorhexidine can cause etching/cracking of the luer lock collar material.Therefore, the reported condition was not verified as a nonconforming product because the cause was determined to be due to the customer¿s disinfecting method.Due to the nature of the returned sample, no additional testing could be performed.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Manufacturer Narrative
Further clarification was received from the customer stating that they are ¿not swabbing the male luer¿ (as a disinfecting method).The customer is priming the set with propofol while keeping the blue cap on the end of the set.The priming may take place quite some time prior to use, however, exact amount of time is unknown.Remove the statement that ¿the cause of the condition was due to the customer¿s disinfecting method¿ (reported on the initial).Update to: the cause of the condition could not be determined; however, based on the sample evaluation, the cause of the condition could have been due to the customer¿s priming method.If the propofol solution contains lipids, it may have a negative effect on polycarbonate.If the user is priming the sets with propofol and the blue tip protector is attached to the male luer, the propofol can back wash up into the male luer collar and have a negative effect.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUO-VENT CLEARLINK LUER ACTIVATED VALVE
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
MDR Report Key11088453
MDR Text Key224759757
Report Number1416980-2020-08139
Device Sequence Number1
Product Code FPA
UDI-Device Identifier00085412048956
UDI-Public(01)00085412048956
Combination Product (y/n)Y
PMA/PMN Number
K112893
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 05/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number2C8419
Device Lot NumberSR20B19083
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/13/2021
Initial Date Manufacturer Received 12/03/2020
Initial Date FDA Received12/29/2020
Supplement Dates Manufacturer Received01/19/2021
05/13/2021
Supplement Dates FDA Received02/05/2021
05/18/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-